US Stock MarketDetailed Quotes

ACIU AC Immune

Watchlist
  • 2.680
  • 0.0000.00%
Close Dec 24 13:00 ET
  • 2.610
  • -0.070-2.61%
Post 16:12 ET
265.17MMarket Cap-6.04P/E (TTM)
Full Hours
  • 5D
  • Daily
  • Weekly
  • Monthly
  • 1Q
  • 1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Comments

    Trytosaveabit
    Trytosaveabit
    Dec 10 06:03
    Update
    $AC Immune (ACIU.US)$ Reuters· 3 mins ago
    AC Immune SA - ACI-24.060 Safe and Well Tolerated in Down Syndrome Patients
    Trytosaveabit
    Trytosaveabit
    Nov 14 06:03
    Update
    $AC Immune (ACIU.US)$ Reuters· 2 mins ago
    AC Immune Reports Positive Interim Results From Phase 2 Trial of ACI-7104.056 Active Immunotherapy in Early Parkinson’s Disease
    Jaguar8
    Jaguar8
    Nov 14 06:02
    NEWS
    $AC Immune (ACIU.US)$
    AC Immune Reports Positive Interim Results from Phase 2 Trial of ACI-7104.056 Active Immunotherapy in Early Parkinson’s Disease
    AC Immune (NASDAQ: ACIU) announced positive interim results from its Phase 2 VacSYn trial of ACI-7104.056, an active immunotherapy for early Parkinson's disease.
    The treatment showed significant efficacy, inducing anti-a-synuclein antibody levels 16-fold higherthan placebo after 3 immunizations, with a 100% patient response rate.
    The trial rep...
    amiable Hedgehog_758
    amiable Hedgehog_758
    Sep 17 06:34
    $AC Immune (ACIU.US)$
    AC Immune Reaches Key Milestone in Alzheimer's Immunotherapy, Receives CHF 24.6M
    Benzinga· 10 mins ago5mins
    AC Immune (ACIU.US)
    3.270
    3.530
    +2.83%
    +7.95%
    AC Immune SA (NASDAQ:ACIU), a clinical-stage biopharmaceutical company pioneering precision therapeutics for neurodegenerative diseases, today announced that it will receive the second ReTain-related milestone payment (CHF 24.6 million) under its agreement with Janssen Pharmaceuticals, Inc. (Janssen), a Johnson & Johnson co...
    Trytosaveabit
    Trytosaveabit
    Sep 17 06:09
    News
    $AC Immune (ACIU.US)$ Press Release: AC Immune Receives Second Milestone Payment Following Progress in Phase 2b ReTain Trial of ACI-35.030 in Preclinical Alzheimer's Disease
    Dow Jones· 7 mins ago
    AC Immune Receives Second Milestone Payment Following Progress in Phase 2b ReTain Trial of ACI-35.030 in Preclinical Alzheimer's Disease
    AC Immune Receives Second Milestone Payment Following Progress in Phase 2b ReTain Trial of ACI-35.030 in Preclinical Alzheimer's Disease
    1
Read more
Trending US Stocks
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks

Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
BTCS Inc
BTCS
+15.59%
Bitdeer Technologies
BTDR
+14.81%
Hut 8
HUT
+12.15%
Digihost Technology
DGHI
+11.73%
Argo Blockchain
ARBK
+10.88%

Unlock the Full List